New eye drops aim to soothe painful corneal abrasions in rare skin disease
NCT ID NCT06713434
First seen Jan 08, 2026 · Last updated May 07, 2026 · Updated 19 times
Summary
This study tests whether ELK-003 eye drops can safely reduce eye symptoms in people with two types of epidermolysis bullosa (junctional and recessive dystrophic). About 20 participants will use the drops six times daily for a set period. The goal is to see if the drops decrease the number of painful corneal abrasions and other eye problems compared to when they received no treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundación DEBRA Chile, Niños Piel de Cristal
Santiago, Huechuraba, 8580670, Chile
Conditions
Explore the condition pages connected to this study.